Mirati Therapeutics' GAAP loss for 2020 was $357.937 million, up 67.8% from $213.256 million in the previous year. Revenue quadrupled to $13.398 million from $3.335 million a year earlier.
Mirati Therapeutics' GAAP loss for 2020 was $357.937 million, up 67.8% from $213.256 million in the previous year. Revenue quadrupled to $13.398 million from $3.335 million a year earlier. 
ir.mirati.com
English (US) 